Quest Diagnostics (DGX) Long-Term Investments (2014 - 2026)

Quest Diagnostics (DGX) has 13 years of Long-Term Investments data on file, last reported at $134.0 million in Q1 2026.

• Quarterly Long-Term Investments changed 0.0% year-over-year to $134.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $134.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $136.0 million, up 10.57% from the prior year.
• Long-Term Investments slipped to $134.0 million in Q1 2026 per DGX's latest filing, from $136.0 million in the prior quarter.
• The five-year high for Long-Term Investments was $155.0 million in Q1 2022, with the low at $123.0 million in Q4 2024.
• Average Long-Term Investments over 5 years is $134.4 million, with a median of $134.0 million recorded in 2025.
• The widest YoY moves for Long-Term Investments: up 32.43% in 2022, down 70.59% in 2022.
• Quest Diagnostics' Long-Term Investments stood at $132.0 million in 2022, then grew by 2.27% to $135.0 million in 2023, then retreated by 8.89% to $123.0 million in 2024, then grew by 10.57% to $136.0 million in 2025, then decreased by 1.47% to $134.0 million in 2026.
• Business Quant data shows DGX's Long-Term Investments at $134.0 million in Q1 2026, $136.0 million in Q4 2025, and $137.0 million in Q3 2025.